Video summary
Medical research operates somewhat like a high-end salesman presenting a beautifully packaged product without ever opening the box to reveal its true contents. While studies are often flashy on the outside and promise significant benefits, researchers rarely allow the public to see the raw data that generated those results; instead, readers only receive the curated narrative presented by the authors. Despite this opacity, the vast majority of scientists are ethical individuals dedicated to advancing healthcare, yet it is crucial for consumers of medical information to understand that what is seen in a published paper does not always reflect the entire reality of the investigation. This gap between the final publication and the underlying data means that readers must learn to critically evaluate what might be hidden inside the "box" of a study.
The journey from an initial idea to a published manuscript is a lengthy and expensive process involving two primary pathways: academia and industry. In academic settings, researchers must spend considerable time writing grants to secure funding, often facing repeated rejections before receiving approval to conduct their studies. Once data is collected and analyzed, the findings are submitted to medical journals for peer review, where anonymous experts critique the work to ensure quality before publication. This entire cycle can take up to a decade, whereas pharmaceutical companies in the industry sector skip the grant-writing phase by using their own substantial funds, though they still undergo the same rigorous peer review process before their results are made public.
Accessing these published studies is often hindered by paywalls that charge readers or institutions for content funded by taxpayer dollars, prompting the rise of open access initiatives. While open access journals aim to make information freely available to everyone, they sometimes introduce high publication fees that can lead to the emergence of predatory journals—fake publications that accept any paper for a fee without genuine peer review. To navigate this landscape, readers can utilize public libraries, databases like PubMed Central which may have a slight delay, Google Scholar, or simply email the corresponding authors to request copies of papers they find interesting, ensuring that valuable scientific knowledge remains accessible despite financial barriers.
Ultimately, the medical research system is driven by several perverse incentives that can compromise the reliability of published science. Academic researchers face pressure to publish frequently to secure promotions and funding, which may encourage them to highlight only successful experiments rather than failures. Similarly, pharmaceutical companies are financially motivated to publish data that portrays their drugs in the most favorable light to increase prescriptions. Recognizing these systemic pressures is essential for understanding that medical science is not a purely neutral activity; therefore, readers must remain vigilant in identifying potential biases and bad behaviors to accurately interpret the studies they encounter.
Read the full video transcript
[Music]
well here we are in the very
first lecture thanks for joining me and
before we get into the nitty-gritty of
how to conduct a medical study or how to
interpret a medical study
we're going to talk in a very broad
sense about how medical research works
in general the 10 000 foot view as we
say
here are the goals of this lecture we're
going to describe the process of medical
research how we get from a to z from a
hypothesis
to a manuscript we're going to talk
about the concept of peer review
we're going to explain what open data
means and what its promises and how that
promise sometimes gets broken
and finally we're going to talk about
some of the perverse
incentives that underlie all of medical
science
but first i want to tell you about the
greatest salesman
in the world imagine you're in the
market for a new food processor
you decide to go to the number one food
processor store in the world the new
england
food processor emporium inside a
salesman shows you a beautiful box
there's a picture on the front a lovely
food processor
with all the bells and whistles there
are multiple testimonials
best food processor i've ever used makes
other food processors look like
a garbage disposal saved my waistline
and my marriage
very impressive stuff you ask the
salesman to open the box to let you
see the miraculous device oh no he says
i can't do that why not well
everything you need to know is on this
box it's really a great food processor
yes but i'd love to you know plug it in
see a demonstration
or something sorry all i can show you is
this box
so what does that have to do with
medical studies well medical studies are
very much like that box that the
salesman had
they are nice and flashy on the outside
and they
tell you all the great things that are
inside but very rarely do you actually
get to see
inside the box you don't get to see the
data that generated all the results in
the medical study
you just get to see what the authors
tell you now
the vast majority of scientific authors
are honest brokers and ethical people
that really do want to advance
health care in the country and the world
but you do have to know
that what you see is not always what you
get and part of this course is going to
be teaching you
how to recognize what might be lying
inside that box
now a lot of times people wonder how can
we be spending so much money on research
and
and it's a great question research costs
a ton of money huge sums are invested
globally in medical research
and development and with good reason
right
the u.s spends more than 100 billion
dollars a year
on medical research and the majority of
that comes from
the federal government in the form of
the national institutes of health
the nih has an annual budget
of 33 billion dollars just a tremendous
amount of money
going towards medical research so what
do you get for that money well
you actually get quite a lot and i think
mary lasker said it best when she said
if you think research is expensive
try disease right and so just to give
you a few examples of
amazing returns on investment the human
genome project was a 3.8 billion dollar
investment
at the federal level just an
unfathomable sum of money
to do a science experiment and yet the
return on that investment is about a
trillion dollars worth of economic
growth and
the explosion of a bunch of new fields
of science so definitely worth it
on a slightly smaller scale but perhaps
no less impressive the women's health
initiative clinical trial which was a
clinical trial which evaluated hormone
replacement after menopause
cost a whopping 250 million dollars to
perform that's a huge sum of money
but resulted in 37 billion dollars of
savings
and economic output in the long run so
medical research costs a lot of money
but you make a lot of money too
now how does research get from the idea
phase to in your hand in a medical study
well
there are basically two paths one is the
path of academia which is where i come
from and one is the path of industry
which are where a lot of our
pharmaceutical companies are lying so
let me give you a story here
this was a paper we published back in
2016. that's
that's me this was one of my papers
looking at a clinical trial
evaluating automated alerts for a
condition called acute kidney injury
and this is what we went through to get
this paper published so first
we had a research question we wondered
if these alerts would benefit people
we developed a hypothesis we said to
ourselves yes we think they will benefit
people in terms of reducing the risk of
death and dialysis and other bad
outcomes that happen to
to patients who have their kidneys
injured we had an idea to test the
hypothesis a randomized trial
and then you come to this critical
question right how are we going to pay
for this
so we just said this costs a lot of
money so you write a grant
grant writing is central to the process
of academic medicine it's what most of
us spend a lot of our time
doing and the way that works is you put
together a big proposal and it can be
upwards of 150 pages
which you submit to a funding agency
that is reviewed by a panel of your
peers presumably
and sent back to you they're often
rejected or called for revision
and that cycle can repeat over and over
and over again until if you are very
lucky and you're working on something
that they are interested in your grant
gets funded then you have the money you
can conduct the study
you collect the data analyze the data
and write up a manuscript but it doesn't
stop there that manuscript that you've
written the results of your study
doesn't just get distributed you know
via the new york times or something you
submit it to a medical journal
and medical journals all want your peers
again
to read your manuscript and criticize it
for them that's a process called
peer review the manuscript will go to
three or four
experts in the field you're talking
about and the experts will
write back with questions what did you
mean by this why didn't you do this
don't you think this is another
explanation for the results you see here
that process can iterate multiple times
as well the manuscript continues to get
changed
finally hopefully it's accepted by that
major medical journal
and the manuscript is published and
that's how you got from a to z
it will not surprise you to hear that
this process can take
a decade between when that idea
emerges in your mind and when that final
paper is published it is a slow process
but it's one that often generates
good results what about industry
so this is an article that appeared in
the new england journal of medicine
looking at a drug called pembrolizumab
to treat a certain type of lung cancer
and broadly speaking the pathway is the
same
industry identifies a promising agent
rather than a question really they
identify a compound that they think
might be active and help treat
a disease they just go ahead and conduct
the study
they've got their own money in fact they
have quite a lot of money so they can
skip over that grant writing step
altogether which must be nice for them
they conduct their study collect the
data analyze their data and write the
manuscript and then
the same process of peer review applies
to them
until eventually the manuscript is
accepted
the two major pathways leading from that
first idea
to that final published manuscript that
you're sitting
reading when you read a medical study
now what is this peer review well we
submit a manuscript and our peers read
through it
they are anonymous we don't know who
they are
and they are sometimes a bit rough when
they respond to us so here are some
examples of peer review
the first one is is one that i received
recently
why the authors think an extremely
convoluted technique developed in
marketing should be taken seriously in
clinical research
where highly competent statisticians
have developed techniques over decades
of research
is mind-boggling that was a less than
constructive piece of criticism but most
peer review is actually pretty good
here's some other examples that i like
since the manuscript is so lacking in
all aspects i won't bother going through
it
in detail not a very productive piece of
peer review
and finally this paper is fluently
written and meticulously researched
i do not recommend it for publication so
peer review
hit or miss but i show you these because
they're kind of funny and it's fun to
to laugh about a little bit but a lot of
peer review is actually really
productive and makes the paper
much better now publication
a lot of people would assume that we
researchers make money when we publish
papers but it's
in fact quite the opposite we are
usually charged
to publish a paper um we uh
in the bigger journals that are more
profitable that charge may be
waived or in certain cases those
journals are free to publish in
but they are not paying you for these
articles in any way
the charges can vary quite a bit
depending on the journal and we'll talk
about some of those charges
especially when we start discussing this
concept of open access journals
but we don't make our salary from
publishing papers at least not directly
now you might think if we've paid to
have our paper published
that you shouldn't have to pay to read
it nevertheless when you go to try to
read it you may run into
any number of pay walls which is of
course how these journals
make their money and there's quite a bit
of criticism that these journals are
essentially making money off the backs
of the taxpayer who is funding all of
this research
and i'll tell you how as a tax payer you
may be able to get around some of these
pay walls but nevertheless the state of
play right now
is that many of these journals do not
give you access to this information for
free at least
not very easily so let's talk about
getting around these payroll paywalls
right
i'm of the firm belief that information
should be free especially information
that you paid for through your tax
dollars right
so how if you see an interesting medical
study how can you
get it how can you get it in your hands
well number one you can ask your local
librarian so
many libraries even just public
libraries municipal libraries
across the country have subscriptions to
multiple
medical journals and so you can just
request this and they will
print it out for you photocopy it for
you not too hard
number two pubmed central so there is a
law that says
if the government funds the research the
research has to be publicly available
and it's
that is published on a place called
pubmed central
now the catch to pubmed central and the
link is right here
is that there's about a year up to a
year lag
between when the paper is published in
the journal and when it appears
on pubmed central so if that is a hot
off the press paper you want to see you
may not see it
in pubmed central when you go there
google scholar
is highly useful if you go to
scholar.google.com and type in the title
of the paper you'll find multiple
listings for it and oftentimes some of
those
are not behind paywalls so take a look
and number four this is almost
universally effective
email the authors the corresponding
author
which is usually either the first or
last author listed in the series of
authors in the paper
will have their email printed on the
abstract of the paper which is usually
in front of the paywall
you simply email them you say i
found your study very interesting would
you mind sending me a copy and i have
never had an experience where an
author declines that so multiple steps
to get around pay walls you should not
have to pay for this especially for
federally funded research that you've
paid for once already
now we're talking about seeing these
papers so i want to talk to you a little
bit about this concept of open access so
open access sounds great the idea behind
open access is
we give you the papers for free open
access
no paywalls read whatever you want
sounds great right but it's a bit of a
two-faced god so the good side
is that it makes this information freely
available to everyone
the papers get seen by more people
broader dissemination more discussion
and some journals are entirely open
access
a famous one is called plos one and you
can go online you can read any paper
that's there
as soon as it gets published you can
look at it great but there's a bit of a
downside right someone has to pay for
this so
the charges to the researchers who are
publishing the paper can be quite high
ranging between two thousand and five
thousand dollars to have their paper
appear
open access now once you introduce that
kind of money they're gonna be people
who take advantage of that and so there
have
um evolved what we call predatory open
access journals these are essentially
fake scientific journals that if you pay
enough money as a researcher
they will publish your paper now why
would you want to do that as a
researcher well it gets into some of the
perverse incentives in medical research
that i wanted to address before we get
too deep into this whole course
now predatory journals reach out to you
all the time and ask you to submit your
articles
and uh i receive maybe 10
emails a day from various journals like
this asking to submit an article and to
show you
that despite the fact that they say that
your article will be rigorously peer
reviewed that is not true
this is a uh an article that appeared
in the journal international journal of
advanced computer technology
called get me off your mailing list and
the
entire article just consisted of the
author writing get me off your
mailing list
over and over and over again it was
accepted after peer review
and published for a fee of course
now this tells you something right the
international journal of advanced
computer technology
sounds legitimate it sounds legitimate
to me how do you know
that the journal you're reading is a
good journal or a predatory
open access journal there are a number
of ways
to tell how good a journal is or how
reputable a journal is
one way is if you know someone in the
field you just ask them have you ever
heard of the international journal of
advanced computer technology and if they
tell you
no i've never heard of it and i'm an
advanced computer technologist then
it's probably not a great journal but
you can look at other ways there's a
concept called the impact factor and you
should know what that is
the impact factor is the average number
of times that a paper
that appears in a journal gets cited so
if i publish a paper in a journal and
it gets cited over the course of the
next year or so you know 50 times
that's a high impact paper a lot of
people are
citing that paper it's an important
paper and so if you take the
average of all those citations across
the entire journal you can say
the average article in this journal gets
cited how many times and here's just a
ranking
of the top impact factors to give you a
sense
of where we are so you can see the
cancer journal for clinicians is very
high up there that's a journal that
publishes mostly review articles
actually
but they do tend to get cited quite a
bit but number two is the new england
journal of medicine many of you will
have heard of that a very
venerable journal one of the top
journals
in in medicine with an impact factor of
72 which tells you that the average
article in the new england journal
gets cited by 72 other articles over
some
defined period of time which is which is
pretty high these predatory journals
might have
impact factors of less than one which is
to say
that the average article doesn't even
get cited once
subsequent to publication so you can
always google the
the journal's impact factor to get a
sense of is this article being published
in a highly reputable journal
now i told you that this is all sort of
corrupted by perverse incentives
for me as an academic why am i paying
money
to publish my research well one is that
i you know i want to get it out there i
want to tell people what we've done
but my job is dependent on how much i
publish
if i don't publish papers and obtain
grants then i
don't advance in my career i don't get
promoted and if
you don't get promoted over a certain
period of time you're kindly asked
to leave and so there's an incentive to
me to publish as much as possible
there's an incentive to me to publish
things that make my lab look good
that make my hypotheses look good
because
i will reference those publications in
future grants and say oh look what great
ideas we have
and that's really bad because we want
everything to be published if i do an
experiment everyone needs to see the
results even if the experiment fails or
else
someone else is going to do the same
experiment and fail again
now pharmaceutical companies have a
different perverse incentive and it's
almost entirely based
on dollars so they
want to publish papers that make their
drug look very good
so that people will prescribe their drug
now there are some rules in place to
prevent gaming the system which we'll
talk about
in a subsequent lecture but you need to
be aware of the fact that the science
the medical science enterprise
is not this pure uh uh
activity you know from sitting lofty on
high in the ivory tower that there are
forces at play that make some of the
research you're going to read
not as reliable as you may think so our
take-home points for today the medical
manuscript
is the end point of a very long process
it takes a long time to get
published you don't get to see much of
that process you just get to see the box
at the end the peer reviewers don't see
much of that either right they just are
reviewing the manuscript they don't get
to see the data
that went into the manuscript or very
rarely do they
systems are in place that make open data
less attractive
to researchers in particular the very
high cost
and finally the medical research system
has many perverse incentives
that encourage some bad behavior so
knowing that bad behavior is out there
you need to know how to identify it
and we'll cover how to identify that
those behaviors through the rest of this
course